✦ LIBER ✦

Entorhinal cortical thickness as a biomarker for preclinical Alzheimer's disease

✍ Scribed by Yassa, Michael; Gallagher, Michela

Book ID: 123135603
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 46 KB
Volume: 9
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2013.08.193

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Deciphering the cortical thickness signa

Deciphering the cortical thickness signature: Biomarker for Alzheimer's disease or for memory?

✍ Irene Meier; Stuart Grieve; Mayuresh Korgaonkar; Molly Zimmerman; Adam Brickman 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Temporoparietal cortical thickness outpe

Temporoparietal cortical thickness outperforms hippocampal volume as a biomarker for atypical and early-onset Alzheimer's disease

✍ Cohn-Sheehy, Brendan; Ghosh, Pia; Wirth, Miranka; Lehmann, Manja; Madison, Cinde 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 391 KB

Temporoparietal cortical thickness outpe

Temporoparietal cortical thickness outperforms hippocampal volume as a biomarker for atypical and early-onset Alzheimer's disease

✍ Cohn-Sheehy, Brendan; Ghosh, Pia; Wirth, Miranka; Lehmann, Manja; Madison, Cinde 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 168 KB

APOE associated hemispheric asymmetry of

APOE associated hemispheric asymmetry of entorhinal cortical thickness in aging and Alzheimer's disease

✍ Donix, Markus; Burggren, Alison C.; Scharf, Maria; Marschner, Kira; Suthana, Nan 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 806 KB

Structural MRI biomarkers for preclinica

Structural MRI biomarkers for preclinical and mild Alzheimer's disease

✍ Christine Fennema-Notestine; Donald J. Hagler Jr.; Linda K. McEvoy; Adam S. Flei 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 535 KB

## Abstract Noninvasive MRI biomarkers for Alzheimer's disease (AD) may enable earlier clinical diagnosis and the monitoring of therapeutic effectiveness. To assess potential neuroimaging biomarkers, the Alzheimer's Disease Neuroimaging Initiative is following normal controls (NC) and individuals w

Complement activation as a biomarker for

Complement activation as a biomarker for Alzheimer's disease

✍ Mohammed Aiyaz; Michelle K. Lupton; Petroula Proitsi; John F. Powell; Simon Love 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 624 KB